글로벌 신경외과 시장 – 2029년까지의 산업 동향 및 예측

신경외과 시장 분석 및 통찰력

의료 분야의 기술 혁신은 임상 실무에 변화를 일으키는 새로운 기술의 도입으로 정의할 수 있습니다. 신경외과는 특히 기술 집약적인 외과 분야이며, 새로운 기술은 수술 신경외과 기술의 많은 주요 발전에 앞섰습니다. 현재는 수술 세션 동안 합병증의 가능성을 줄일 수 있는 최소 침습 장치를 개발하는 데 중점을 두고 있습니다. 최소 침습 기술이 도입됨에 따라 의사는 전동 공구, 신경혈관 색전술 장치, 감마 나이프와 같은 방사선 수술 시스템과 같은 고도로 전문화된 수술 도구를 사용하고 있습니다.

또한, 강화된 규제 기준과 신경 질환의 증가와 같은 새로운 요인들이 첨단 치료 프로토콜의 채택과 이러한 치료법이 더 널리 이용 가능할 것이라는 가정으로 이어졌습니다. 이로 인해 산업과 정부의 무편차에 대한 수요가 증가했고, 이는 신경외과 서비스에 대한 수요를 촉진했으며, 산업 간 제휴와 협업의 증가는 신경외과 시장을 활성화할 것으로 예상되는 주요 요인입니다. 그러나 신경내시경 장비 및 시술에 관련된 더 높은 비용과 훈련된 전문가의 부족은 예측 기간 동안 시장 성장을 제한할 수 있습니다.

Data Bridge Market Research는 글로벌 신경외과 시장이 2029년까지 20,679.72백만 달러에 도달할 것으로 예상하고 있으며, 예측 기간 동안 CAGR은 14.2%입니다. "제품 유형"은 전 세계적으로 환자 수가 증가함에 따라 시장에서 가장 큰 유형 세그먼트를 차지합니다. 이 시장 보고서는 또한 가격 분석, 특허 분석 및 심층적인 기술 발전을 다룹니다.

글로벌 신경외과 시장 정의

The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy, and Parkinson's disease. These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, stereotactic systems, catheters, pacemakers, single- and dual-chamber defibrillators, and implantable cardioverter defibrillators among others, that are used in a variety of neurosurgical procedures. Neurosurgery aids in the diagnosis of patients who have brain tumors, spinal cord injuries brought by accidents, neck and back discomfort, and abnormal spinal fluid movement. Around 7 to 10 million people worldwide suffer from Parkinson's disease. Neurological illness is one of the main causes of morbidity and disability worldwide. During the forecast period, technological developments in neurosurgery are anticipated to drive the market. The rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery market across the globe. In addition, advances in neurological surgeries such as 3-dimension reconstruction for brain tumor surgery, X-knife radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery market.

Global Neurosurgery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

• Technological advancement in neurosurgery

Since the beginning of modern neurosurgery, technological advancements have paved the way for a more thorough and enhanced understanding of cerebral form and function to more effectively treat complex pathologies affecting patients. Technological advancements brought a transition from conventional equipment toward energy-efficient equipment based on novel technology. Several cutting-edge techniques help neurosurgeries quite easily. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. Image guidance and neuromodulation devices demonstrated a highly correlated rapid rise in patents and publications, suggesting they are areas of technology expansion which is expected to boost the market growth.

With the growth in the prevalence of neurological conditions, the demand for neurosurgery is also increasing. The market is expected to grow in the forecast period.

Moreover, the adoption of endoscopic techniques' is a significant market advancement. Additionally, recovery time is shorter in neurosurgeries. Thus, all these factors are expected to act as drivers for market growth.

• Rising prevalence of neurological conditions

The World Health Organization (WHO) focuses on research in areas that are important for public health promotion. Recently, WHO has been particularly interested in frequent and disabling neurological disorders with a high burden on the world. Neurological disorders occur among all age groups and different geographical regions. They significantly contribute to morbidity and mortality around the world. The neurological burden of disease is expected to grow exponentially in low- and middle-income countries (LMICs) in the next decade.

The rising prevalence of neurological conditions such as transnasal hemorrhage, intracerebral hemorrhage (ICH), traumatic brain injury, chronic pain, depression, and Parkinson's is expected to drive market growth.

Thus, increasing neurological disorders such as transnasal hemorrhage and intracerebral hemorrhage (ICH) are fueling market growth. Neurological conditions have become a major public health crisis which is expected to boost the growth of the global neurosurgery market.

Restraint

• The high cost associated with neurosurgeries and equipment

A significant increase in the cost of neurosurgical products has been observed in recent years, which end users such as hospitals and neurosurgical centers have to incur. Products such as neurovascular embolization devices, neurovascular coiling devices, and neuroendoscopes are quite costly. Manufacturers are also giving more resources to research and development to introduce cost-effective and advanced technology. Some complex neurosurgeries require extensive time as well as effort, and they are also quite risky. These complex procedures need advanced techniques and skills, and because of this, the cost of equipment and neurosurgeries increases. The maintenance of such facilities and continuous requirement of power supply add up to the cost of the surgeries. Decompressive craniectomy for traumatic brain injury (TBI) is an expensive procedure that is also associated with high morbidity and mortality.

The cost associated with neurosurgery procedures is quite high, which is expected to act as a restrain for the market growth.

Opportunity

• Rising awareness about neurological disorders

With the rising global population, a large portion of the geriatric section is getting affected by neurological disorders such as epilepsy, Parkinson's disease, stroke, brain tumor, dementia, and multiple sclerosis, among others. So, understanding neurological disorders is important, and awareness about neurological conditions can lead to seeking medical attention, which results in proper diagnosis and effective treatment. All neurological disorders account for 82.8%. The massive fold increases the burden of neurological disorders that can be attributed to a lack of awareness about neurological disorders and treatment, which lead to delayed detection, and lack of access to quality healthcare and rehabilitation centers. Rising healthcare programs and increasing funding from governments and public healthcare agencies help reduce the burden of neurological disorders and develop neurological products that act in favor of market growth.

Rising awareness about neurological disorders is beneficial for the neurosurgery market. In most regions, many governmental and non-governmental are carry some awareness programs for the early detection of neurological conditions.

Challenge

• Alternative treatments for neurological disease

Drug therapies are the first line of treatment for the treatment of neurological conditions. Neurosurgical procedures are opted only if non-surgical treatments are not effective. Complementary and alternative treatments are increasingly employed to supplement neurosurgical treatment in neurosurgery. This includes acupuncture, naturopathic medicine, chiropractic treatment, and ayurvedic medicine among others. More recently, doctors have become increasingly receptive to the use of alternative treatments, and scientific studies on the safety and effectiveness of complementary and alternative options are taken through the national institutes of health, which may act as a challenge to the growth of the neurosurgery market.

Thus, alternative treatment options are expected to offer significant challenges for the global neurosurgical market. 

Post-COVID-19 Impact on Global Neurosurgery Market

The COVID-19 outbreak had a drastic effect on global healthcare, with the U.K., U.S., China, South Africa, and others, amongst the countries most severely impacted. The pandemic has had a negative impact on the neurosurgery market growth on account of the temporary halt in research activities in this field, coupled with the low influx of patients in hospitals and diagnostic centers. Moreover, the impact of COVID-19 pandemic on neurosurgical products delivery is challenging the neurosurgeons for getting delivery of surgical products.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology in the neurosurgery market.

Recent Developments

• In March 2022, Medtronic, a leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products
• In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app
• In April 2022, Boston Scientific Corporation or its affiliates announced it had received U.S. Food and Drug Administration (FDA) approval for its latest image-guided programming software, Vercise Neural Navigator, with STIMVIEW XT. Developed in collaboration with Brainlab AG, a leading software-driven medical technology company. This has helped the company to expand its product portfolio
• In October 2020, Accuray Incorporated announced a collaboration with Brainlab AG, a market leader in digital surgery and precision radiotherapy that will enhance and expand the Accuray CyberKnife treatment platform for the neuro-radiosurgery market. Both companies are partnering to provide the neuro-radiosurgery community with access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons. This has helped the company to expand its business

Global Neurosurgery Market Scope

The global neurosurgery market is segmented into product type, application, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

By Product Type

• Neurosurgery devices
• Neurosurgery software
• Consumables

On the basis of product type, the global neurosurgery market is segmented into neurosurgery devices, neurosurgery software, and consumables.

By Application

• Aneurysms
• Arteriovenous malformation (AVM)
• Brain tumors
• Carotid artery blockage/stenosis
• Cerebrovascular surgery
• Cortical mapping
• Epilepsy
• Functional neurosurgery
• Intraoperative angiography
• Parkinson's disease and tremors
• Peripheral nerve surgery
• Pituitary tumors
• Radiosurgery
• Skull base surgery
• Spine surgery
• Stereotactic neurosurgery
• Trauma surgery
• Trigeminal neuralgia
• Others

On the basis of application, the global neurosurgery market is segmented into aneurysms, arteriovenous malformation (AVM), brain tumors, carotid artery blockage/stenosis, cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others.

By Age Group

• Pediatric
• Adult
• Geriatric

On the basis of end user, the global neurosurgery market is segmented into pediatric, adult, and geriatric.

By End User

• Hospitals
• Research centers
• Neurosurgery centers
• Ambulatory surgical centers (ASCS)
• Others

On the basis of end user, the global neurosurgery market is segmented into hospitals, neurosurgery centers, research centers, ambulatory surgical centers, and others.

By Distribution Channel

• Direct tender
• Third party distributors
• Others

On the basis of distribution channel, the global neurosurgery market is segmented into direct tender, third party distributors, and others.

Global Neurosurgery Market Regional Analysis/Insights

The global neurosurgery market is analyzed, and market size information is provided by product type, application, age group, end user, and distribution channel.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia, and rest of Asia-Pacific, U.A.E., Israel, South Africa, Saudi Arabia, Egypt, and rest of the Middle East and Africa, Brazil, Argentina, and the rest of South America.

In 2022, North America is expected to dominate the global neurosurgery market due to the presence of key market players in the largest consumer market with high GDP. The U.S. is expected to grow due to the rise in technological advancement in neurosurgical equipment. The increasing investment in R&D and the increasing adoption of neurosurgery as an option for the formulation of treatment regimens are expected to boost market growth. The U.S. dominates North America region due to the strong presence of advanced technology providers such as Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, and others. The U.K. is expected to dominate the Europe region due to the increasing demand from emerging markets and the expansion of healthcare industries. China is expected to dominate the Asia-Pacific region due to an increase in healthcare expenditure.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 글로벌 신경외과 시장 점유율 분석

글로벌 신경외과 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선입니다. 제공된 위의 데이터 포인트는 글로벌 신경외과 시장에 대한 회사의 초점과만 관련이 있습니다.

글로벌 신경외과 시장의 주요 기업으로는 Medtronic, Abbott, Boston Scientific Corporation 또는 그 계열사, Elekta, ALEVA NEUROTHERAPEUTICS, Machida Endoscope Co., Ltd., Brainlab AG, adeor medical AG., LivaNova PLC, B. Braun SE, Optofine Instruments Pvt. Ltd., Wallaby Medical, Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Nalu Medical, Inc., Renishaw plc., Synapse Biomedical Inc., EMS Handels Gesellschaft mbH, Inomed Medizintechnik GmbH, BIOINDUCTION, ANT Neuro, Advantis Medical Imaging, Leica Microsystems 등이 있습니다.

연구 방법론: 글로벌 신경외과 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가에게 전화를 요청하십시오.

SKU-53312